Research is being conducted on the metabolic characteristics of various diseases, including systemic sclerosis, multiple sclerosis, and systemic lupus erythematosus. Studies are using techniques such as metabolomic profiling and clinical metabolomics to identify altered metabolic patterns and potential biomarkers for these diseases. The findings may have implications for diagnosis and therapeutic strategies, although the specific focus and outcomes of the research are not clearly defined.